top of page
The Professional Network for Healthcare Experts
Henlius receives Pakistan approval for adalimumab biosimilar HANDAYUAN
Henlius has received approval in Pakistan for HANDAYUAN, its adalimumab biosimilar, marking the product's first regulatory approval outside China.
nuaxia
Sep 171 min read
Henlius and Sandoz expand biosimilars partnership to cover up to 10 global programmes
The portfolio collaboration combines Henlius’ biologics development and manufacturing capabilities with Sandoz’s ex-China commercial infrastructure, initially covering three biosimilars and an option on a recombinant human hyaluronidase programme.
nuaxia
Aug 193 min read
bottom of page